Pharmaceutical Updates

Amgen and AstraZeneca Present Groundbreaking Oncology Data at ESMO, Demonstrating a 58% Reduction in Risk of Death for Small Cell Lung Cancer

Amgen and AstraZeneca presented practice-changing Phase 3 clinical data at the European Society for Medical Oncology (ESMO) 2026 Congress, demonstrating that frontline maintenance therapy combining Imdelltra (tarlatamab-dlle)and Imfinzi (durvalumab) cut the risk of...

​Next-Generation MAKO 4 Robotic-Assisted Surgery System Officially Launched to Advance Precision in Joint Replacement

In a major development for orthopedic surgical technology, medical device innovators and surgical teams have celebrated the official rollout of...

​Indian Pharmacopoeia Commission Issues Drug Safety Alert Linking Levetiracetam and Topical Decongestants to Specific Adverse Reactions

The Indian Pharmacopoeia Commission (IPC), functioning as the National Coordination Centre for the Pharmacovigilance Programme of India (NCC-PvPI)...

Rising Yields Hit Sun Pharma’s Fundraising Drive as Bond Issue Misses ₹10,000 Crore Goal

India’s largest drugmaker by market capitalisation Sun Pharmaceutical Industries has raised ₹7,816 crore (~8000 cr) against its ₹10,000-crore fundraising target, highlighting the growing...

GLP-1 Boom: China, India and Brazil Could Unlock a $22 Billion Market by 2035 , J.P. Morgan Estimates

The market for GLP-1 medicines across China, India and Brazil could surge from $6.6 billion currently to $22 billion...

Telangana & South Africa Forge Strategic Alliance in Pharma, Medical Tourism, and ‘Bharat Future City

Telangana Chief Minister A Revanth Reddy hosted a high-level bilateral meeting with a South African delegation led by Deputy President Paul Mashatile to expand...

24 Nations, One Standard — India’s Pharmacopoeia Goes Global

The Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding with Lao PDR's Food and Drug Department and Ministry of Health, marking a...

CDSCO Advises Pharma Companies to Track and Report Drug Side Effects

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued a firm directive to all medicine manufacturers to build and maintain proper...

Emcure and Roche Collaborate to Improve Access to Advanced Nephrology Care

Emcure Pharmaceuticals has entered into a distribution agreement with Roche India for select products in nephrology and transplantation, marking a strategic step in expanding...

India’s Lupin and Natco Pharma Secure U.S. FDA Approval for Eribulin Mesylate Injection

On 03rd June, 2026 Lupin Limited (Lupin) announced that, Lupin and its alliance partner Natco Pharma Limited (Natco) got the approval from the United States Food and Drug Administration (U.S. FDA)...

Alkem Launches India’s First Semaglutide Pre-Filled Syringes at Just INR 350

Alkem Laboratories Ltd. a leading Indian pharmaceutical company, today announced the groundbreaking launch of semaglutide in multiple dose strengths utilizing a single-shot pre-filled syringe...